Ansell Limited (ASX:ANN)
45.14
+0.04 (0.09%)
Oct 9, 2026, 4:10 PM AEST
Ansell Market Cap
Ansell has a market cap or net worth of 6.26 billion as of October 9, 2026. It is the 4,047th most valuable company in the world and the 76th biggest in Australia. Its market cap has increased by 34.18% in one year.
Market Cap
6.26B
Enterprise Value
7.04B
Revenue
3.09B
Global Rank
Country Rank
#76 Australia
PE Ratio
21.52
ChartMarket Cap Chart
Since January 16, 1992, Ansell's market cap has increased from 5.00B to 6.26B, an increase of 25.40%. That is a compound annual growth rate of 0.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 6.26B | 25.58% |
| Dec 31, 2025 | 4.99B | 1.96% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.90B |
| Sigma Healthcare | 30.14B |
| Pro Medicus | 16.57B |
| Ramsay Health Care | 12.56B |
| Sonic Healthcare | 9.24B |
| Cochlear | 8.44B |
| Telix Pharmaceuticals | 5.39B |
| Neuren Pharmaceuticals | 2.57B |